Cargando…
The role of dexamethasone in the modification of misonidazole pharmacokinetics.
A review of misonidazole pharmacokinetics in 83 consecutive patients treated for tumours other than glioma has shown that among patients not receiving enzyme-inducing agents the plasma elimination half life is lower in patients taking steroids. Such a difference is not seen if patients already takin...
Autores principales: | Jones, D. H., Bleehen, N. M., Workman, P., Walton, M. I. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011507/ https://www.ncbi.nlm.nih.gov/pubmed/6626454 |
Ejemplares similares
-
Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.
por: Honess, D. J., et al.
Publicado: (1980) -
The penetration of misonidazole into spontaneous canine tumours.
por: White, R. A., et al.
Publicado: (1979) -
Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
por: Lee, F. Y., et al.
Publicado: (1983) -
Monitoring salivary misonidazole in man: a possible alternative to plasma monitoring.
por: Workman, P., et al.
Publicado: (1978) -
Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity.
por: Workman, P., et al.
Publicado: (1980)